Traws Pharma, Inc.
TRAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001130598
No open-market purchases or sales by Traws Pharma, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $5.19M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Traws Pharma, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 28 | 34 | +6 |
| Shares | 3.62M | 6.16M | +2.54M (+70.1%) |
| Value | $6.62M | $5.19M | −$1.43M (−21.6%) |
New holders (13)
Institutions that held Traws Pharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 786,236 | $663.0K | 0.85% |
| Sphera Funds Management Ltd. | 398,486 | $336.0K | 0.05% |
| Alyeska Investment Group, L.P. | 164,376 | $138.6K | 0.00% |
| HRT Financial LP | 91,220 | $76.0K | 0.00% |
| Kynam Capital Management, LP | 84,400 | $71.2K | 0.00% |
| Northern Trust Corp | 37,454 | $31.6K | 0.00% |
| XTX Topco Ltd | 18,092 | $15.3K | 0.00% |
| SG Americas Securities, LLC | 14,524 | $12.0K | 0.00% |
| Virtu Financial LLC | 12,579 | $11.0K | 0.00% |
| Huntington National Bank | 4,676 | $3.94K | 0.00% |
| Barclays PLC | 1,947 | $1.64K | 0.00% |
| Federation des caisses Desjardins du Quebec | 500 | $414 | 0.00% |
| Harbour Investments, Inc. | 5 | $4 | 0.00% |
Sold out (7)
Institutions that held Traws Pharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Squadron Capital Management LLC | 511,714 | $936.4K |
| Palumbo Wealth Management LLC | 61,175 | $112.0K |
| Two Sigma Investments, LP | 19,244 | $35.2K |
| Robinswood Financial LLC | 5 | $9 |
| Northwestern Mutual Wealth Management Co | 2 | $4 |
| Caitong International Asset Management Co., Ltd | 2 | $4 |
| Royal Bank of Canada | 6 | $0 |